Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/27/2024
CASI Receives China Business Buyout Proposal from Its Chairman & CEO
6/27/2024
Novo Nordisk to Limit Wegovy Sales in China amid Supply Shortage
6/27/2024
Review of Chinese Hospital Drug Sales: Market Trends and Leading TCs
6/27/2024
Industry Braces for Biosecure Act Impact (C&EN)
6/26/2024
On Efficiency of China's Drug-Related Patent Term Compensation System ...
6/25/2024
Fosun to Take Henlius Biotech Private in HK$13.37B Bid
6/25/2024
NMPA Solicits Comments on Major Document on Optimizing the Review and ...
6/25/2024
Novo Nordisk's Wegovy Approved in China for Weight Loss
6/24/2024
Over 75% of Township Health Centers and Community Health Service Cente...
6/21/2024
Review of Chinese Pharmaceutical Market Segmentation 2019-2023
6/21/2024
Review of Chinese Drug Market Performance of Seven Leading MNCs 2016-2...
6/21/2024
Recent Official and Executive Moves
6/20/2024
Fosun to Reduce Its Stake in India's Gland Pharma
6/20/2024
Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials
6/20/2024
Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
6/19/2024
Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
6/19/2024
Day One Biopharma Nabs ex-China Rights of MabCare's ADC MTX-13
6/19/2024
China Allocates More Urban Medical Resources to Lower-level Healthcare...
6/18/2024
China Biopharma Tracker – May 2024 (PharmaDJ)
6/17/2024
FDA Halts MediLink-BioNTech's ADC Trial After Three Fatalities
6/14/2024
Takeda, Ascentage Enter into Global License Deal for Olverembatinib
6/14/2024
Recent Official and Executive Moves
6/14/2024
In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
6/13/2024
NHSA Solicits Comments on Drafts of the Working Plan and the Applicati...
6/13/2024
Ethypharm Expands Its Mesalazine (Etiasa) Portfolio in China
6/13/2024
AbbVie and FutureGen Enter License Deal to Develop Next-Gen Therapy fo...
6/12/2024
WuXi PharmaTech Buoyed Amid Uncertainties on BIOSECURE Act's Legislati...
6/12/2024
NMPA Issues the Technical Guidelines for Electronic Recording of Blood...
6/12/2024
NMPA Issues Revised Blood Product Appendix of Chinese Drug GMP 2010
6/7/2024
Novo Nordisk Faces Stiff Generic Competition in China’s Weight-Loss D...
Page:
24
/
354
Total number of articles:
10618
:
[First]
[<<]
[22]
[23]
[24]
[25]
[26]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit